Tag Archive | "cancer"

Big pharma, Astellas joins hands with UK cancer non-profits

Tags: , , ,


Cancer Research UK and Cancer Research Technology are to join forces with big pharma, Astellas Pharma to find new drug targets in the fight against cancer, with an initial focus on pancreatic cancer. Read the full story

Industry analysis: Cancer monoclonal antibody partnering on the rise

Tags: , ,


Monoclonal antibodies are developed to be very selective in targeting cells. This is why they have come to be an indispensable research tool in cancer treatment being able to specifically target tumor cells.

Read the full story

Eli lilly and Immunocore sign a biotech deal for cancer therapies

Tags: , ,


Eli Lilly and Company have entered into a biotech deal for co-development collaboration to research and potentially develop novel T cell-based cancer therapies. Read the full story

J&J and Dana-Farber sign a 3 year pharma partnering deal

Tags: , , , ,


Johnson & Johnson Innovation and Janssen Biotech announced a three-year immuno-oncology lung cancer pharma partnering deal  with the Dana-Farber Cancer Institute. Read the full story

Cancer vaccine

Tags: , ,


A cancer vaccine is a vaccine that treats existing cancer or prevents the development... Read the full story

Roche and Molecular Partners enter into a pharma licensing deal

Tags: , , , ,


Roche and Molecular Partners have entered into a research collaboration and licensing agreement for $1.169 billion. Read the full story

Merck Serono signs a pharma licensing deal with BeiGene

Tags: , , ,


Merck Serono announced that a global pharma licensing, co-development, and commercialization agreement for BeiGene-290 has been signed with BeiGene for $232 million. Read the full story

Roche forms a pharma alliances with immatics biotechnology

Tags: , , , ,


immatics biotechnologies forms a pharma alliances with Roche for a strategic research and development collaboration covering multiple cancer vaccines and immunotherapeutics for $1.017billion.

Read the full story

Eli Lilly in licensing pharma deals with ImmunoGen for anti-cancer technology

Tags: , , ,


ImmunoGen licensed an anticancer technology to Eli Lilly and Co in pharma deals that could be worth $200 million in milestone payments plus royalties on sales of any commercialized drugs. Read the full story

MedImmune M&A deals for Amplimmune in $500 million acquisition

Tags: , , ,


MedImmune enters into M&A deals for the acquisition of Amplimmune for a total consideration of $500 million. Read the full story